A carregar...

Local delivery of dinutuximab from lyophilized silk fibroin foams for treatment of an orthotopic neuroblastoma model

Immunotherapy targeting GD2 is a primary treatment for patients with high‐risk neuroblastoma. Dinutuximab is a monoclonal antibody with great clinical promise but is limited by side effects such as severe pain. Local delivery has emerged as a potential mechanism to deliver higher doses of therapeuti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Ornell, Kimberly J., Taylor, Jordan S., Zeki, Jasmine, Ikegaki, Naohiko, Shimada, Hiroyuki, Coburn, Jeannine M., Chiu, Bill
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7163090/
https://ncbi.nlm.nih.gov/pubmed/32096344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2936
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!